Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

NCT05718609 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

855

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Rabeprazole
DRUG: Colloidal Bismuth Pectin Granules
DRUG: Amoxicillin
DRUG: Furazolidone
DRUG: Clarithromycin

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University